Shots:

• Abbott’s next-generation- sensor-based glucose monitoring technology- FreeStyle Libre 2- received Health Canada’s approval for adults & children with diabetes
• The system continuously measures glucose data every minute with customizable- optional real-time alarms to alert users when their glucose is high/low without scanning
• The technology sustains performance for ~14days- providing trends- insights & actionable data on a reader or with the FreeStyle LibreLink mobile app. FreeStyle Libre 2 will be available for people with diabetes aged ≥4yrs. in Canada in the coming months

 ­ Ref: PRNewswire | Image: Abbott